Glenmark, Actavis Sued By Sanofi For Patent Infringement Of Heart Drug
This article was originally published in PharmAsia News
Executive Summary
Glenmark has been sued in a U.S. court by Sanofi, which accused the India drug maker of infringing the patent for its Multaq (dronedarone) for treating atrial fibrillation in certain patients.